Antibodies against ErbB3 and uses thereof

Details for Australian Patent Application No. 2008216600 (hide)

Owner Merrimack Pharmaceuticals, Inc.

Inventors Nielsen, Ulrik; Schoeberl, Birgit; Feldhaus, Michael

Agent Shelston IP

Pub. Number AU-A-2008216600

PCT Pub. Number WO2008/100624

Priority 61/009,796 02.01.08 US; 60/901,904 16.02.07 US

Filing date 15 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/100624 Priority application(s): WO2008/100624

29 April 2010 Amendment Made

  The nature of the amendment is: Add co-inventor Muruganandam, Arumugam; Buckler, David

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216602-Support structure for a flexible razor blade assembly

2008216585-System and method for tracking the movement of biological materials